ERO1B and pancreatic neoplasm: In relation to lung cancer, ERO1B has been recently identified as a gene that, together with an additional three genes identified using TCGA LUAD dataset, is able to predict patient prognosis [52] and has been suggested to be a biomarker for pancreatic cancer [53,54].